MFDS — authorised 20 November 1964
- Marketing authorisation holder: SANOFI AVENTIS US
- Status: likely_approved
🇰🇷 Norpramin in South Korea
MFDS authorised Norpramin on 20 November 1964
Marketing authorisation
Norpramin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in South Korea
Frequently asked questions
Is Norpramin approved in South Korea?
Yes. MFDS authorised it on 20 November 1964.
Who is the marketing authorisation holder for Norpramin in South Korea?
SANOFI AVENTIS US holds the South Korean marketing authorisation.